{"count": 2, "results": [{"_id": "24285770", "pmid": 24285770, "title": "Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia.", "journal": "Ann Pharmacother", "authors": ["Lyster RL", "Houle SK"], "date": "2013-11-01T00:00:00Z", "doi": "10.1177/1060028013504385", "meta_date_publication": "2013 Nov", "meta_volume": "47", "meta_issue": "11", "meta_pages": "1581-3", "score": 50066.758, "text_hl": "Abnormal @<m>DISEASE_Uterine_Hemorrhage</m> @DISEASE_MESH:D014592 @@@vaginal bleeding@@@ following pharmacist prescribing of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ leads to the detection of complex @DISEASE_Endometrial_Hyperplasia @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@.", "citations": {"NLM": "Lyster RL, Houle SK. Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia. Ann Pharmacother. 2013 Nov;47(11):1581-3. PMID: 24285770", "BibTeX": "@article{24285770, title={Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia.}, author={Lyster RL and Houle SK}, journal={Ann Pharmacother}, volume={47}, number={11}, pages={1581-3}}"}}, {"_id": "25556427", "pmid": 25556427, "title": "Antiproliferative effect of metformin on the endometrium--a clinical trial.", "journal": "Asian Pac J Cancer Prev", "authors": ["Tabrizi AD", "Melli MS", "Foroughi M", "Ghojazadeh M", "Bidadi S"], "date": "2014-01-01T00:00:00Z", "doi": "10.7314/apjcp.2014.15.23.10067", "meta_date_publication": "2014", "meta_volume": "15", "meta_issue": "23", "meta_pages": "10067-70", "score": 50060.47, "text_hl": "MATERIALS AND METHODS: A total of 43 @SPECIES_9606 @@@patients@@@ who were referred to our center for @<m>DISEASE_Uterine_Hemorrhage</m> @DISEASE_MESH:D014592 @@@abnormal uterine bleeding@@@ and had a histologic diagnosis were @DISEASE_Endometrial_Neoplasms @DISEASE_MESH:D016889 @@@disordered proliferative endometrium@@@ or simple @DISEASE_Endometrial_Hyperplasia @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@ were included and randomly distributed in two groups treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (500mg @CHEMICAL_4_benzamido_4'_isothiocyanostilbene_2_2'_disulfonate @CHEMICAL_MESH:C032526 @@@Bid@@@) or @CHEMICAL_Megestrol @CHEMICAL_MESH:D008535 @@@megestrol@@@ (40mg daily), respectively, for three months. ", "citations": {"NLM": "Tabrizi AD, Melli MS, Foroughi M, Ghojazadeh M, Bidadi S. Antiproliferative effect of metformin on the endometrium--a clinical trial. Asian Pac J Cancer Prev. 2014;15(23):10067-70. PMID: 25556427", "BibTeX": "@article{25556427, title={Antiproliferative effect of metformin on the endometrium--a clinical trial.}, author={Tabrizi AD and Melli MS and Foroughi M and Ghojazadeh M and Bidadi S}, journal={Asian Pac J Cancer Prev}, volume={15}, number={23}, pages={10067-70}}"}}]}